When the level of autophagy induced by drug action on tumor cells is increased, the Beclin-1-Bcl-2 complex may be dissociated, thus producing autophagy-promoting and anti-apoptotic effects on tumor cells [76]. The gene discussed is BCL2; the disease is neoplasm.